The European Union is one of the world's most demanding biotechnology markets, and the penalty for falling behind its evolving requirements is severe: delayed clinical development, damaging inspection findings, escalating remediation costs, and restricted market access. As the EU Clinical Trials Regulation (EU) No. 536/2014 and CTIS reshape trial authorization and oversight, robust compliance across clinical evidence, product quality, pharmacovigilance, data integrity, and inspection readiness is no longer optional, it is the safeguard that protects your programs and your organization's access to Europe.
This certified program is designed to give you a comprehensive and in-depth command of these complex regulatory frameworks and equip you with the expertise to navigate the EU biotech landscape with authority. You will gain critical insight into the key areas, including the Clinical Trials Regulation, ICH GCP compliance, Advanced Therapy Medicinal Products (ATMP) pathways, biologics licensing requirements, CMC (Chemistry, Manufacturing and Controls) expectations and the centralized and decentralized approval processes within the European Medicines Agency framework. You will also master essential topics such as pharmacovigilance systems, safety reporting, regulatory submissions, and the integration of GDPR requirements into clinical and research operations.
Furthermore, this program arms you with practical strategies to embed regulatory compliance into biotech product development, clinical trial design, and lifecycle management. This includes managing multi-country clinical trials and adapting decisively to evolving regulatory updates and scientific standards. You will also gain insight into effective regulatory risk management, audit readiness, and the use of digital systems for compliant data governance and reporting. By the end of the program, you will be fully equipped to navigate complex regulatory pathways, mitigate compliance risks, and accelerate the successful development and commercialization of biotech products within the EU.
Upon successful completion, you will be awarded the Certification in EU Biotech Regulations and Clinical Compliance, validating your expertise in EU biotechnology regulation and clinical-trial compliance. This distinguished credential demonstrates your ability to support product approvals, navigate evolving regulatory expectations, and lead with confidence on lifecycle compliance.
1 Chartered Institute of Professional Certifications' reviews and ratings are a comprehensive collection of participants feedback we have gathered over the last decade. To view authentic and personal testimonials that are handwritten by our participants, please download our participants' written reviews here.
This program will entitle you:
Pricing & Registration- Experience 2 days of instructor-led live training and develop a practical command of EU biotechnology regulation, clinical trial compliance, and the lifecycle requirements that decide market access.
- Earn the industry-recognized Certification in EU Biotech Regulations and Clinical Compliance, proving your professional capability across regulatory compliance, clinical trials, and lifecycle management.
- Apply proven techniques to navigate CTR and CTIS requirements, strengthen GCP compliance, and elevate your documentation, building a far stronger foundation for inspection readiness and successful regulatory submissions.
- For inquiries, please reach our Program Advisors at [email protected] or call us at
- Singapore and Asia Pacific: +65 6716 9980
- Australia and New Zealand: +61 3 9909 7310
- UK, Europe and Middle East: +44 (020) 335 57898
- Canada: +1 833 879 8820
- USA: +1 888 745 8875
Accreditations
This program is accredited by the Chartered Institute of Professional Certifications, which maintains the governing standards for all professionals who have completed this program.
The content of this program has been fully certified and accredited by CPD Certification Service as conforming to Continuing Professional Principles. CPD is the leading independent CPD accreditation institution operating across industry sectors to complement the Continuing Professional Development policies of professional institutes and academic bodies. The CPD Certification Service provides support, advice and recognized independent CPD accreditation compatible with global CPD principles.
What Can You Expect From This Live Program
EU’s biotech regulations and clinical compliance landscape is among the most complex globally - developing and approving biotech products in the EU demands simultaneous approvals from multiple regulatory frameworks, including the Clinical Trials Regulation, Advanced Therapy Medicinal Products requirements, pharmacovigilance obligations, and the strict data protection standards imposed by GDPR. In practice, over 60% of biotech companies report delays or additional costs driven by regulatory complexity, while a substantial proportion of applications face multiple rounds of review before meeting the EU’s rigorous standards for safety, efficacy, and ethical compliance.
This certified program will sharpen your ability to interpret the EU regulatory landscape, apply CTR and CTIS requirements, and manage sponsor responsibilities with authority. You will strengthen your capacity to maintain ICH GCP-compliant practices, produce genuinely defensible documentation, and close compliance gaps decisively. These capabilities will help you eliminate avoidable risk and build regulatory strategies that hold up throughout clinical development.
You will develop practical expertise in ATMP requirements, CMC compliance, and GMP quality systems, alongside marketing authorization, dossier strategy, and pharmacovigilance. By aligning clinical evidence with quality expectations, you will be fully equipped to drive product development forward and answer regulatory scrutiny with confidence. This integrated command will improve submission quality, protect product integrity, and accelerate more effective regulatory decision-making.
Through case-based learning and applied exercises, you will apply ALCOA+ data integrity principles, assess digital compliance risks, conduct rigorous regulatory gap assessments, and develop effective CAPAs. You will strengthen inspection readiness and learn to coordinate decisively across clinical, quality, and regulatory teams, building a cohesive compliance framework that holds across the entire biotechnology lifecycle.
Upon successful completion, you will earn the Certification in EU Biotech Regulations and Clinical Compliance, validating your expertise in EU biotechnology regulation, clinical trial compliance, and lifecycle regulatory management. This globally recognized credential demonstrates your capability to command compliance readiness, drive successful product approvals, and navigate evolving EU regulatory requirements with confidence.
Key Skills You Will Gain
- EU Biotech Regulations
- Clinical Trial Compliance
- CTR Compliance Management
- CTIS Submission Management
- ICH GCP Compliance
- Clinical Trial Oversight
- Regulatory Strategy Development
- Regulatory Lifecycle Management
- ATMP Regulatory Compliance
- Clinical Evidence Strategy
- CMC Compliance Management
- GMP Compliance
- Quality Systems Management
- Marketing Authorization Strategy
- Regulatory Dossier Preparation
- Pharmacovigilance Management
- Safety Risk Management
- Clinical Data Integrity
- ALCOA+ Compliance
- Digital Regulatory Compliance
- GDPR Compliance
- Inspection Readiness
- Audit Readiness
- Regulatory Gap Assessment
- CAPA Management
- Regulatory Risk Management
- Cross Functional Compliance
- Regulatory Documentation
- Regulatory Intelligence
- Biotech Lifecycle Compliance
Your Faculty Director
Dr. Tatsiana Ripich is a highly accomplished regulatory, clinical, and quality affairs expert with extensive experience across European regulatory affairs, clinical compliance, and product lifecycle management. Holding a Ph.D. in Cell Biology and RAC Devices certification, she combines deep scientific expertise with hands-on regulatory experience spanning competent authorities, global industry, MedTech, and consulting.
Her career includes service at the German Federal Institute for Drugs and Medical Devices (BfArM), giving her first-hand insight into how clinical trial and pharmacovigilance requirements are genuinely assessed and enforced. She currently holds senior leadership responsibilities across Regulatory, Clinical, and Quality Affairs, guiding strategy from development and clinical evidence through regulatory submissions and quality compliance.
Dr. Ripich has participated in regulatory inspections, including an FDA inspection, and advises life-science organizations on EU regulatory strategy, clinical evidence, Quality Management Systems, and inspection readiness. An experienced trainer and international speaker, she is widely recognized for translating the most complex regulatory requirements into clear, practical compliance strategies.
EU Biotech Regulations and Clinical Compliance Program Agenda
How You Will Benefit From This Program
- Master EU Biotech Regulatory Requirements: Build a commanding understanding of the EU biotechnology regulatory landscape, its key authorities, and its approval pathways so you can identify and apply the relevant requirements with certainty rather than guesswork.
- Navigate CTR and CTIS Requirements: Manage sponsor and clinical trial obligations decisively, elevate your documentation, and maintain fully compliant practices throughout the clinical trial lifecycle.
- Apply ICH GCP and Ethical Standards: Sharpen your command of ICH GCP principles, ethical requirements, and risk-based quality management to protect trial integrity and keep your clinical practices inspection-ready at all times.
- Navigate ATMP Regulatory Requirements: Develop authoritative expertise in ATMP regulation, advanced therapy development, and evidence requirements so you can master the regulatory complexities surrounding innovative biotechnology products.
- Strengthen CMC and GMP Compliance: Command CMC expectations, quality-control strategies, and GMP requirements so you can elevate manufacturing compliance and maintain defensible quality systems throughout development.
- Build Effective Regulatory Approval Strategies: Learn how to sharpen regulatory strategy and dossier preparation while aligning clinical evidence and quality requirements to drive successful EU marketing authorization.
- Manage Pharmacovigilance and Safety Risks: Develop practical command of pharmacovigilance obligations, risk management, and lifecycle safety strategy to strengthen post-authorization compliance and oversight.
- Strengthen Data Integrity and Inspection Readiness: Apply ALCOA+ principles, digital compliance controls, gap assessments, and CAPA practices to elevate documentation quality, expose weaknesses early, and stand ready for regulatory scrutiny.
- Build an Integrated Lifecycle Compliance Strategy: Translate regulatory requirements into clear compliance priorities that connect clinical, quality, safety, and regulatory activities from development through post-market oversight.
Certification in EU Biotech Regulations and Clinical Compliance
Upon successfully completing this program, you will be awarded the Certification in EU Biotech Regulations and Clinical Compliance, ready to be added to your resume, CV, and professional credentials. This certification is industry-recognized and carries lifelong validity.
This certification is powerful and lasting proof of your expertise in EU biotechnology regulation, clinical trial compliance, and lifecycle regulatory management. It validates your capability to navigate the most complex regulatory requirements, strengthen clinical compliance, and drive successful product development and approval. It also demonstrates your readiness to command inspection requirements and evolving compliance expectations across the biotechnology lifecycle. This program is developed by the Chartered Institute of Professional Certifications, and its content has been certified by CPD Certification Service as adhering to the highest standards of continuing professional principles.
Pricing & Registration
Europe
Dates: 01 - 02 Mar 2027
Venue: Online Executive Program (via Zoom)
Time: 9:00am - 4:30pm British Summer Time (BST)
10:00am - 5.30pm Central European Summer Time (CEST)
| Early Bird Packages | Regular Pricing | ||
|---|---|---|---|
| By 22 Dec 2026 | By 02 Feb 2027 | After 02 Feb 2027 | |
| EU Delegates | EUR 1,295 | EUR 1,495 | EUR 1,595 |
| Switzerland Delegates | CHF 1,195 | CHF 1,395 | CHF 1,495 |
| UK Delegates | GBP 1,095 | GBP 1,295 | GBP 1,395 |
Group Discount: 2nd participant get 10%, or register 3 participants and 4th participant get a complimentary seat (1 discount scheme applies)
Register NowDownload Brochure
Download our program brochure below. For any inquiries, please reach our Program Advisor at [email protected] or call us directly at:
- Singapore and Asia Pacific: +65 6716 9980
- Australia and New Zealand: +61 3 9909 7310
- UK, Europe and Middle East: +44 (020) 335 57898
- Canada: +1 833 879 8820
- USA: +1 888 745 8875
Convincing Your Boss To Attend This Program
Securing approval is far easier when the organizational value is made explicit. We have prepared a ready-to-use manager approval template that demonstrates precisely how this program strengthens EU biotechnology regulatory compliance, clinical trial management, submission quality, inspection readiness, and lifecycle compliance capabilities.
Simply download the template, personalize it where required, and share it with your manager to make a compelling case for your attendance.
EU Biotech Regulations and Clinical Compliance
4.6 (919 ratings)